Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > NF1(Gene name) > Human
  • Add your favorite
  • NF1 (Gene name),
  • Neurofibromin (Protein name ),  NF1_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    NF1;
    Protein name:
    Neurofibromin;
    Alternative:
    Neurofibromatosis-related protein NF-1;
    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    N/A
    Function:
    Stimulates the GTPase activity of Ras. NF1 shows greater affinity for Ras GAP, but lower specific activity. May be a regulator of Ras activity.
    Subcellular Location:
    N/A
    Protein Attributes:
    Sequence length:
    2839
    Sequence:
    50:
    MAAHRPVEWV | QAVVSRFDEQ | LPIKTGQQNT | HTKVSTEHNK | ECLINISKYK | 
    100:
    FSLVISGLTT | ILKNVNNMRI | FGEAAEKNLY | LSQLIILDTL | EKCLAGQPKD | 
    150:
    TMRLDETMLV | KQLLPEICHF | LHTCREGNQH | AAELRNSASG | VLFSLSCNNF | 
    200:
    NAVFSRISTR | LQELTVCSED | NVDVHDIELL | QYINVDCAKL | KRLLKETAFK | 
    250:
    FKALKKVAQL | AVINSLEKAF | WNWVENYPDE | FTKLYQIPQT | DMAECAEKLF | 
    300:
    DLVDGFAEST | KRKAAVWPLQ | IILLILCPEI | IQDISKDVVD | ENNMNKKLFL | 
    350:
    DSLRKALAGH | GGSRQLTESA | AIACVKLCKA | STYINWEDNS | VIFLLVQSMV | 
    400:
    VDLKNLLFNP | SKPFSRGSQP | ADVDLMIDCL | VSCFRISPHN | NQHFKICLAQ | 
    450:
    NSPSTFHYVL | VNSLHRIITN | SALDWWPKID | AVYCHSVELR | NMFGETLHKA | 
    500:
    VQGCGAHPAI | RMAPSLTFKE | KVTSLKFKEK | PTDLETRSYK | YLLLSMVKLI | 
    550:
    HADPKLLLCN | PRKQGPETQG | STAELITGLV | QLVPQSHMPE | IAQEAMEALL | 
    600:
    VLHQLDSIDL | WNPDAPVETF | WEISSQMLFY | ICKKLTSHQM | LSSTEILKWL | 
    650:
    REILICRNKF | LLKNKQADRS | SCHFLLFYGV | GCDIPSSGNT | SQMSMDHEEL | 
    700:
    LRTPGASLRK | GKGNSSMDSA | AGCSGTPPIC | RQAQTKLEVA | LYMFLWNPDT | 
    750:
    EAVLVAMSCF | RHLCEEADIR | CGVDEVSVHN | LLPNYNTFME | FASVSNMMST | 
    800:
    GRAALQKRVM | ALLRRIEHPT | AGNTEAWEDT | HAKWEQATKL | ILNYPKAKME | 
    850:
    DGQAAESLHK | TIVKRRMSHV | SGGGSIDLSD | TDSLQEWINM | TGFLCALGGV | 
    900:
    CLQQRSNSGL | ATYSPPMGPV | SERKGSMISV | MSSEGNADTP | VSKFMDRLLS | 
    950:
    LMVCNHEKVG | LQIRTNVKDL | VGLELSPALY | PMLFNKLKNT | ISKFFDSQGQ | 
    1000:
    VLLTDTNTQF | VEQTIAIMKN | LLDNHTEGSS | EHLGQASIET | MMLNLVRYVR | 
    1050:
    VLGNMVHAIQ | IKTKLCQLVE | VMMARRDDLS | FCQEMKFRNK | MVEYLTDWVM | 
    1100:
    GTSNQAADDD | VKCLTRDLDQ | ASMEAVVSLL | AGLPLQPEEG | DGVELMEAKS | 
    1150:
    QLFLKYFTLF | MNLLNDCSEV | EDESAQTGGR | KRGMSRRLAS | LRHCTVLAMS | 
    1200:
    NLLNANVDSG | LMHSIGLGYH | KDLQTRATFM | EVLTKILQQG | TEFDTLAETV | 
    1250:
    LADRFERLVE | LVTMMGDQGE | LPIAMALANV | VPCSQWDELA | RVLVTLFDSR | 
    1300:
    HLLYQLLWNM | FSKEVELADS | MQTLFRGNSL | ASKIMTFCFK | VYGATYLQKL | 
    1350:
    LDPLLRIVIT | SSDWQHVSFE | VDPTRLEPSE | SLEENQRNLL | QMTEKFFHAI | 
    1400:
    ISSSSEFPPQ | LRSVCHCLYQ | ATCHSLLNKA | TVKEKKENKK | SVVSQRFPQN | 
    1450:
    SIGAVGSAMF | LRFINPAIVS | PYEAGILDKK | PPPRIERGLK | LMSKILQSIA | 
    1500:
    NHVLFTKEEH | MRPFNDFVKS | NFDAARRFFL | DIASDCPTSD | AVNHSLSFIS | 
    1550:
    DGNVLALHRL | LWNNQEKIGQ | YLSSNRDHKA | VGRRPFDKMA | TLLAYLGPPE | 
    1600:
    HKPVADTHWS | SLNLTSSKFE | EFMTRHQVHE | KEEFKALKTL | SIFYQAGTSK | 
    1650:
    AGNPIFYYVA | RRFKTGQING | DLLIYHVLLT | LKPYYAKPYE | IVVDLTHTGP | 
    1700:
    SNRFKTDFLS | KWFVVFPGFA | YDNVSAVYIY | NCNSWVREYT | KYHERLLTGL | 
    1750:
    KGSKRLVFID | CPGKLAEHIE | HEQQKLPAAT | LALEEDLKVF | HNALKLAHKD | 
    1800:
    TKVSIKVGST | AVQVTSAERT | KVLGQSVFLN | DIYYASEIEE | ICLVDENQFT | 
    1850:
    LTIANQGTPL | TFMHQECEAI | VQSIIHIRTR | WELSQPDSIP | QHTKIRPKDV | 
    1900:
    PGTLLNIALL | NLGSSDPSLR | SAAYNLLCAL | TCTFNLKIEG | QLLETSGLCI | 
    1950:
    PANNTLFIVS | ISKTLAANEP | HLTLEFLEEC | ISGFSKSSIE | LKHLCLEYMT | 
    2000:
    PWLSNLVRFC | KHNDDAKRQR | VTAILDKLIT | MTINEKQMYP | SIQAKIWGSL | 
    2050:
    GQITDLLDVV | LDSFIKTSAT | GGLGSIKAEV | MADTAVALAS | GNVKLVSSKV | 
    2100:
    IGRMCKIIDK | TCLSPTPTLE | QHLMWDDIAI | LARYMLMLSF | NNSLDVAAHL | 
    2150:
    PYLFHVVTFL | VATGPLSLRA | STHGLVINII | HSLCTCSQLH | FSEETKQVLR | 
    2200:
    LSLTEFSLPK | FYLLFGISKV | KSAAVIAFRS | SYRDRSFSPG | SYERETFALT | 
    2250:
    SLETVTEALL | EIMEACMRDI | PTCKWLDQWT | ELAQRFAFQY | NPSLQPRALV | 
    2300:
    VFGCISKRVS | HGQIKQIIRI | LSKALESCLK | GPDTYNSQVL | IEATVIALTK | 
    2350:
    LQPLLNKDSP | LHKALFWVAV | AVLQLDEVNL | YSAGTALLEQ | NLHTLDSLRI | 
    2400:
    FNDKSPEEVF | MAIRNPLEWH | CKQMDHFVGL | NFNSNFNFAL | VGHLLKGYRH | 
    2450:
    PSPAIVARTV | RILHTLLTLV | NKHRNCDKFE | VNTQSVAYLA | ALLTVSEEVR | 
    2500:
    SRCSLKHRKS | LLLTDISMEN | VPMDTYPIHH | GDPSYRTLKE | TQPWSSPKGS | 
    2550:
    EGYLAATYPT | VGQTSPRARK | SMSLDMGQPS | QANTKKLLGT | RKSFDHLISD | 
    2600:
    TKAPKRQEME | SGITTPPKMR | RVAETDYEME | TQRISSSQQH | PHLRKVSVSE | 
    2650:
    SNVLLDEEVL | TDPKIQALLL | TVLATLVKYT | TDEFDQRILY | EYLAEASVVF | 
    2700:
    PKVFPVVHNL | LDSKINTLLS | LCQDPNLLNP | IHGIVQSVVY | HEESPPQYQT | 
    2750:
    SYLQSFGFNG | LWRFAGPFSK | QTQIPDYAEL | IVKFLDALID | TYLPGIDEET | 
    2800:
    SEESLLTPTS | PYPPALQSQL | SITANLNLSN | SMTSLATSQH | SPGIDKENVE | 
    2839:
    LSPTTGHCNS | GRTRHGSASQ | VQKQRSAGSF | KRNSIKKIV
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    Pfam:
    Pfam:
    UniGene:
    KEGG:
    String:
    MIM:
    SMR:
    Uniprot:
     
    FOR
    ELISA Kit for Human Neurofibromin
    Cat.:
    E8710h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human Neurofibromin
    MSDS:
    Please sign in first.
    ELISA Kit for Human Neurofibromin
    Cat.:
    E8710m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    ELISA Kit for Human Neurofibromin
    Cat.:
    E8710r
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human Neurofibromin
    Cat.:
    U8710m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human Neurofibromin
    MSDS:
    Please sign in first.
    CLIA Kit for Human Neurofibromin
    Cat.:
    U8710h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    CLIA Kit for Human Neurofibromin
    Cat.:
    U8710r
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Polyclonal Antibody for Human Neurofibromin
    Polyclonal Antibody for Human Neurofibromin
    Polyclonal Antibody for Human Neurofibromin
    Cat.:
    P8710Rb-h
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human Neurofibromin
    Cat.:
    P8710Rb-m
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Monoclonal Antibody for Human Neurofibromin
    Monoclonal Antibody for Human Neurofibromin
    Monoclonal Antibody for Human Neurofibromin
    Monoclonal Antibody for Human Neurofibromin
    Protein for Human Neurofibromin
    Protein for Human Neurofibromin
    Protein for Human Neurofibromin
    Protein for Human Neurofibromin

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      "Exon 10b of the NF1 gene represents a mutational hotspot and harbors a recurrent missense mutation Y489C associated with aberrant splicing."
      Messiaen L.M. , Callens T. , Roux K.J. , Mortier G.R. , De Paepe A. , Abramowicz M. , Pericak-Vance M.A. , Vance J.M. , Wallace M.R.
      Genet. Med.1:248-253(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT NF1 PRO-508
    2. 2.
      "Complete human NF1 cDNA sequence: two alternatively spliced mRNAs and absence of expression in a neuroblastoma line."
      Bernards A. , Haase V.H. , Murthy A.E. , Menon A. , Hannigan G.E. , Gusella J.F.
      DNA Cell Biol.11:727-734(1992) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2)
    3. 3.
      "Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients."
      Wallace M.R. , Marchuk D.A. , Andersen L.B. , Letcher R. , Odeh H.M. , Saulino A.M. , Fountain J.W. , Brereton A. , Nicholson J. , Mitchell A.L. , Brownstein B.H. , Collins F.S.
      Science249:181-186(1990) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)
    4. 4.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ERRATUM
    5. 5.
      "cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product."
      Marchuk D.A. , Saulino A.M. , Tavakkol R. , Swaroop M. , Wallace M.R. , Andersen L.B. , Mitchell A.L. , Gutmann D.H. , Boguski M.S. , Collins F.S.
      Genomics11:931-940(1991) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)
    6. 6.
      "Molecular cloning of a cDNA coding for neurofibromatosis type 1 protein isoform lacking the domain related to ras GTPase-activating protein."
      Suzuki H. , Takahashi K. , Kubota Y. , Shibahara S.
      Biochem. Biophys. Res. Commun.187:984-990(1992) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3);ALTERNATIVE SPLICING
      tissue: Placenta.
    7. 7.
      "Evidence for the presence of two amino-terminal isoforms of neurofibromin, a gene product responsible for neurofibromatosis type 1."
      Suzuki H. , Takahashi K. , Shibahara S.
      Tohoku J. Exp. Med.175:225-233(1995) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5)
      tissue: Kidney.
    8. 8.
      NIEHS SNPs program
      Submitted (2004-11) to the EMBL/GenBank/DDBJ databases
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA];VARIANTS CYS-80; LEU-678; HIS-1422 AND LEU-2511
    9. 10.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
    10. 11.
      "A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations."
      Cawthon R.M. , Weiss R. , Xu G. , Viskochil D. , Culver M. , Stevens J. , Robertson M. , Dunn D. , Gesteland R. , O'Connell P. , White R.
      Cell62:193-201(1990) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 335-2839 (ISOFORM 1);VARIANT NF1 PRO-1953
    11. 12.
      "The neurofibromatosis type 1 gene encodes a protein related to GAP."
      Xu G. , O'Connell P. , Viskochil D. , Cawthon R.M. , Robertson M. , Culver M. , Dunn D. , Stevens J. , Gesteland R. , White R. , Weiss R.
      Cell62:599-608(1990) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 335-2839 (ISOFORMS 1 AND 6)
    12. 13.
      "Emergence and scattering of multiple neurofibromatosis (NF1)-related sequences during hominoid evolution suggest a process of pericentromeric interchromosomal transposition."
      Regnier V. , Meddeb M. , Lecointre G. , Richard F. , Duverger A. , Nguyen V.C. , Dutrillaux B. , Bernheim A. , Danglot G.
      Hum. Mol. Genet.6:9-16(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 707-782
    13. 14.
      "Genomic organization of the neurofibromatosis 1 gene (NF1)."
      Li Y. , O'Connell P. , Breidenbach H.H. , Cawthon R.M. , Stevens J. , Xu G. , Neil S. , Robertson M. , White R. , Viskochil D.
      Genomics25:9-18(1995) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 751-1611 (ISOFORMS 1 AND 2)
    14. 15.
      "The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21."
      Martin G.A. , Viskochil D. , Bollag G. , McCabe P.C. , Crosier W.J. , Haubruck H. , Conroy L. , Clark R. , O'Connell P. , Cawthon R.M. , Innis M. , McCormick F.
      Cell63:843-849(1990) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1090-1598 (ISOFORM 4)
    15. 16.
      "Differential expression of two types of the neurofibromatosis type 1 (NF1) gene transcripts related to neuronal differentiation."
      Nishi T. , Lee P.S. , Oka K. , Levin V.A. , Tanase S. , Morino Y. , Saya H.
      Oncogene6:1555-1559(1991) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1168-1566 (ISOFORMS 1 AND 2)
    16. 17.
      "A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity."
      Andersen L.B. , Ballester R. , Marchuk D.A. , Chang E. , Gutmann D.H. , Saulino A.M. , Camonis J. , Wigler M. , Collins F.S.
      Mol. Cell. Biol.13:487-495(1993) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1371-1391 (ISOFORM 2);FUNCTION;TISSUE SPECIFICITY
    17. 18.
      "Brain tumors predominantly express the neurofibromatosis type 1 gene transcripts containing the 63 base insert in the region coding for GTPase activating protein-related domain."
      Suzuki Y. , Suzuki H. , Kayama T. , Yoshimoto T. , Shibahara S.
      Biochem. Biophys. Res. Commun.181:955-961(1991) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1371-1391 (ISOFORM 2)
    18. 19.
      "The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins."
      Ballester R. , Marchuk D.A. , Boguski M.S. , Saulino A.M. , Letcher R. , Wigler M. , Collins F.S.
      Cell63:851-859(1990) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION
    19. 20.
      "The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing."
      Skuse G.R. , Cappione A.J. , Sowden M. , Metheny L.J. , Smith H.C.
      Nucleic Acids Res.24:478-485(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: RNA EDITING
    20. 21.
      "C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme."
      Mukhopadhyay D. , Anant S. , Lee R.M. , Kennedy S. , Viskochil D. , Davidson N.O.
      Am. J. Hum. Genet.70:38-50(2002) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: RNA EDITING
    21. 22.
      "Molecular basis of neurofibromatosis type 1 (NF1): mutation analysis and polymorphisms in the NF1 gene."
      Upadhyaya M. , Shaw D.J. , Harper P.S.
      Hum. Mutat.4:83-101(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW ON VARIANTS
    22. 23.
      "Molecular genetics of neurofibromatosis type 1 (NF1)."
      Shen M.H. , Harper P.S. , Upadhyaya M.
      J. Med. Genet.33:2-17(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW ON VARIANTS
    23. 24.
      "Neurofibromin is actively transported to the nucleus."
      Vandenbroucke I. , Van Oostveldt P. , Coene E. , De Paepe A. , Messiaen L.
      FEBS Lett.560:98-102(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: SUBCELLULAR LOCATION;NUCLEAR LOCALIZATION SIGNAL
    24. 25.
      "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis."
      Cantin G.T. , Yi W. , Lu B. , Park S.K. , Xu T. , Lee J.-D. , Yates J.R. III
      J. Proteome Res.7:1346-1351(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Cervix carcinoma.
    25. 26.
      "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle."
      Daub H. , Olsen J.V. , Bairlein M. , Gnad F. , Oppermann F.S. , Korner R. , Greff Z. , Keri G. , Stemmann O. , Mann M.
      Mol. Cell31:438-448(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Cervix carcinoma.
    26. 27.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-864; SER-2188; SER-2515; SER-2521 AND SER-2543;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Cervix carcinoma.
    27. 28.
      "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach."
      Gauci S. , Helbig A.O. , Slijper M. , Krijgsveld J. , Heck A.J. , Mohammed S.
      Anal. Chem.81:4493-4501(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    28. 29.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    29. 30.
      "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."
      Mayya V. , Lundgren D.H. , Hwang S.-I. , Rezaul K. , Wu L. , Eng J.K. , Rodionov V. , Han D.K.
      Sci. Signal.2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-864; SER-876 AND SER-2515;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Leukemic T-cell.
    30. 31.
      "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."
      Olsen J.V. , Vermeulen M. , Santamaria A. , Kumar C. , Miller M.L. , Jensen L.J. , Gnad F. , Cox J. , Jensen T.S. , Nigg E.A. , Brunak S. , Mann M.
      Sci. Signal.3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-864 AND SER-2817;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Cervix carcinoma.
    31. 32.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    32. 33.
      "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation."
      Rigbolt K.T. , Prokhorova T.A. , Akimov V. , Henningsen J. , Johansen P.T. , Kratchmarova I. , Kassem M. , Mann M. , Olsen J.V. , Blagoev B.
      Sci. Signal.4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2543 AND SER-2817;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    33. 34.
      "5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia."
      Meffre J. , Chaumont-Dubel S. , Mannoury la Cour C. , Loiseau F. , Watson D.J. , Dekeyne A. , Seveno M. , Rivet J.M. , Gaven F. , Deleris P. , Herve D. , Fone K.C. , Bockaert J. , Millan M.J. , Marin P.
      EMBO Mol. Med.4:1043-1056(2012) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH HTR6
    34. 35.
      "Structural analysis of the GAP-related domain from neurofibromin and its implications."
      Scheffzek K. , Ahmadian M.R. , Wiesmuller L. , Kabsch W. , Stege P. , Schmitz F. , Wittinghofer A.
      EMBO J.17:4313-4327(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 1198-1551
    35. 36.
      "A novel bipartite phospholipid-binding module in the neurofibromatosis type 1 protein."
      D'Angelo I. , Welti S. , Bonneau F. , Scheffzek K.
      EMBO Rep.7:174-179(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 1581-1837;LIPID-BINDING;DOMAIN;MUTAGENESIS OF LYS-1691; ARG-1695; ARG-1769 AND LYS-1771
    36. 37.
      "The sec14 homology module of neurofibromin binds cellular glycerophospholipids: mass spectrometry and structure of a lipid complex."
      Welti S. , Fraterman S. , D'Angelo I. , Wilm M. , Scheffzek K.
      J. Mol. Biol.366:551-562(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 1566-1837 IN COMPLEX WITH PHOSPHOLIPID;LIPID-BINDING;DOMAIN
    37. 38.
      "Structural and biochemical consequences of NF1 associated nontruncating mutations in the Sec14-PH module of neurofibromin."
      Welti S. , Kuhn S. , D'Angelo I. , Brugger B. , Kaufmann D. , Scheffzek K.
      Hum. Mutat.32:191-197(2011) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.19 ANGSTROMS) OF 1581-1837 OF VARIANT NF1 VAL-1605 AND MUTANT LYS-1771 DEL IN COMPLEX WITH LIPID;CHARACTERIZATION OF VARIANT NF1 VAL-1605;MUTAGENESIS OF LYS-1771;LIPID-BINDING;DOMAIN
    38. 39.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT GLU-1444
    39. 40.
      "Analysis of mutations at the neurofibromatosis 1 (NF1) locus."
      Upadhyaya M. , Shen M.H. , Cherryson A. , Farnham J. , Maynard J. , Huson S.M. , Harper P.S.
      Hum. Mol. Genet.1:735-740(1992) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS NF1 MET-2164 AND ASN-2192
    40. 41.
      "Tandem duplication within a neurofibromatosis type 1 (NF1) gene exon in a family with features of Watson syndrome and Noonan syndrome."
      Tassabehji M. , Strachan T. , Sharland M. , Colley A. , Donnai D. , Harris R. , Thakker N.
      Am. J. Hum. Genet.53:90-95(1993) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT GLY-HIS-GLU-GLN-GLN-LYS-LEU-PRO-ALA-ALA-THR-LEU-ALA-LEU-1733 INS
    41. 42.
      "Neurofibromatosis type 1 (NF1): the search for mutations by PCR-heteroduplex analysis on Hydrolink gels."
      Shen M.H. , Harper P.S. , Upadhyaya M.
      Hum. Mol. Genet.2:1861-1864(1993) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT MET-991 DEL
    42. 43.
      "Characterisation of inherited and sporadic mutations in neurofibromatosis type-1."
      Purandare S.M. , Lanyon W.G. , Connor J.M.
      Hum. Mol. Genet.3:1109-1115(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS NF1 ASP-1166 AND ARG-1440
    43. 44.
      "Two NF1 mutations: frameshift in the GAP-related domain, and loss of two codons toward the 3' end of the gene."
      Abernathy C.R. , Colman S.D. , Kousseff B.G. , Wallace M.R.
      Hum. Mutat.3:347-352(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT NF1 2387-ASN-PHE-2388 DEL
    44. 45.
      "Characterisation of germline mutations in the neurofibromatosis type 1 (NF1) gene."
      Upadhyaya M. , Maynard J. , Osborn M.J. , Huson S.M. , Ponder M. , Ponder B.A.J. , Harper P.S.
      J. Med. Genet.32:706-710(1995) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT NF1 ALA-2631
    45. 46.
      "Scanning the first part of the neurofibromatosis type 1 gene by RNA-SSCP: identification of three novel mutations and of two new polymorphisms."
      Gasparini P. , D'Agruma L. , de Cillis G.P. , Balestrazzi P. , Mingarelli R. , Zelante L.
      Hum. Genet.97:492-495(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT NF1 ARG-629
    46. 47.
      "Neurofibromatosis type I gene mutation in a patient with features of LEOPARD syndrome."
      Wu R. , Legius E. , Robberecht W. , Dumoulin M. , Cassiman J.-J. , Fryns J.-P.
      Hum. Mutat.8:51-56(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT NF1 ARG-1035
    47. 48.
      "Mutational and functional analysis of the neurofibromatosis type 1 (NF1) gene."
      Upadhyaya M. , Osborn M.J. , Maynard J. , Kim M.R. , Tamanoi F. , Cooper D.N.
      Hum. Genet.99:88-92(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS NF1 SER-1412; GLN-1440; GLU-1444 AND GLY-1489
    48. 49.
      "Characterization and significance of nine novel mutations in exon 16 of the neurofibromatosis type 1 (NF1) gene."
      Maynard J. , Krawczak M. , Upadhyaya M.
      Hum. Genet.99:674-676(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS NF1 ARG-844 AND PRO-898
    49. 50.
      "Novel and recurrent mutations in the neurofibromatosis type 1 (NF1) gene."
      Hudson J. , Wu C.L. , Tassabehji M. , Summers E.M. , Simon S. , Super M. , Donnai D. , Thakker N.
      Hum. Mutat.9:366-367(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT NF1 ARG-1952
    50. 51.
      "Six novel mutations in the neurofibromatosis type 1 (NF1) gene."
      Upadhyaya M. , Maynard J. , Osborn M.J. , Harper P.S.
      Hum. Mutat.10:248-250(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS NF1 GLY-338 AND TRP-1611
    51. 52.
      "Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1 (NF1)."
      Klose A. , Ahmadian M.R. , Schuelke M. , Scheffzek K. , Hoffmeyer S. , Gewies A. , Schmitz F. , Kaufmann D. , Peters H. , Wittinghofer A. , Nuernberg P.
      Hum. Mol. Genet.7:1261-1268(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT NF1 PRO-1276
    52. 53.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT NF1 GLY-1204;VARIANT HIS-765
    53. 54.
      "A novel mutation L1425P in the GAP-region of the NF1 gene detected by temperature gradient gel electrophoresis (TGGE)."
      Peters H. , Hess D. , Fahsold R. , Schuelke M.
      Hum. Mutat.13:337-337(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT NF1 PRO-1446
    54. 55.
      "Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain."
      Fahsold R. , Hoffmeyer S. , Mischung C. , Gille C. , Ehlers C. , Kuecuekceylan N. , Abdel-Nour M. , Gewies A. , Peters H. , Kaufmann D. , Buske A. , Tinschert S. , Nuernberg P.
      Am. J. Hum. Genet.66:790-818(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS NF1 PRO-216; PRO-357; CYS-491; PRO-549; THR-581; ARG-583; PHE-665; PRO-695; PRO-763; SER-777; LYS-780; PRO-781; PRO-847; SER-1156; PRO-1250; GLN-1276; PRO-1276; PRO-1446; VAL-1605 AND ILE-2507;VARIANT GLU-176
    55. 56.
      "Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1."
      Ars E. , Serra E. , Garcia J. , Kruyer H. , Gaona A. , Lazaro C. , Estivill X.
      Hum. Mol. Genet.9:237-247(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS NF1 SER-117; TRP-1204; PRO-1446 AND 2387-ASN-PHE-2388 DEL
    56. 57.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ERRATUM
    57. 58.
      "NF1 gene analysis focused on CpG-rich exons in a cohort of 93 patients with neurofibromatosis type 1."
      Boulandet E.G. , Pantel J. , Cazeneuve C. , Van Gijn M. , Vidaud D. , Lemay S. , Martin J. , Zeller J. , Revuz J. , Goossens M. , Amselem S. , Wolkenstein P.
      Hum. Mutat.16:274-275(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT NF1 PHE-844
    58. 59.
      "Spinal neurofibromatosis without cafe-au-lait macules in two families with null mutations of the NF1 gene."
      Kaufmann D. , Mueller R. , Bartelt B. , Wolf M. , Kunzi-Rapp K. , Hanemann C.O. , Fahsold R. , Hein C. , Vogel W. , Assum G.
      Am. J. Hum. Genet.69:1395-1400(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT SPINAL FSNF PRO-2088
    59. 60.
      "Evaluation of denaturing high performance liquid chromatography (DHPLC) for the mutational analysis of the neurofibromatosis type 1 ( NF1) gene."
      Han S.S. , Cooper D.N. , Upadhyaya M.N.
      Hum. Genet.109:487-497(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS NF1 LYS-780; CYS-784; PRO-1147; CYS-1193; ARG-1444; SER-1785; ASN-2012 AND LYS-2357
    60. 61.
      "NF1 mutations in neurofibromatosis 1 patients with plexiform neurofibromas."
      Kluwe L. , Friedrich R.E. , Korf B. , Fahsold R. , Mautner V.-F.
      Hum. Mutat.19:309-309(2002) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS NF1 PHE-82; ARG-784 AND GLU-1444
    61. 62.
      "Different mutations in the NF1 gene are associated with neurofibromatosis-Noonan syndrome (NFNS)."
      Baralle D. , Mattocks C. , Kalidas K. , Elmslie F. , Whittaker J. , Lees M. , Ragge N. , Patton M.A. , Winter R.M. , ffrench-Constant C.
      Am. J. Med. Genet. A119:1-8(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT NFNS GLU-1459 DEL
    62. 63.
      "Neurofibromatosis type 1 gene as a mutational target in a mismatch repair-deficient cell type."
      Wang Q. , Montmain G. , Ruano E. , Upadhyaya M. , Dudley S. , Liskay R.M. , Thibodeau S.N. , Puisieux A.
      Hum. Genet.112:117-123(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS NF1 TYR-93; VAL-604; ARG-844 AND PRO-898;VARIANTS ASP-74; GLU-176; ARG-712 AND GLN-1276
    63. 64.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS NF1 LYS-780; PRO-847; GLU-848 AND ARG-968; ASN-1444; LEU-1953 DEL AND ARG-2001
    64. 65.
      "NF1 mutations and clinical spectrum in patients with spinal neurofibromas."
      Kluwe L. , Tatagiba M. , Fuensterer C. , Mautner V.F.
      J. Med. Genet.40:368-371(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS NF1 ARG-578; PRO-920 AND ALA-2221
    65. 66.
      "Disruption of exonic splicing enhancer elements is the principal cause of exon skipping associated with seven nonsense or missense alleles of NF1."
      Zatkova A. , Messiaen L. , Vandenbroucke I. , Wieser R. , Fonatsch C. , Krainer A.R. , Wimmer K.
      Hum. Mutat.24:491-501(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT NF1 VAL-186;CHARACTERIZATION OF VARIANT NF1 VAL-186
    66. 67.
      "Novel and recurrent mutations in the NF1 gene in Italian patients with neurofibromatosis type 1."
      De Luca A. , Schirinzi A. , Buccino A. , Bottillo I. , Sinibaldi L. , Torrente I. , Ciavarella A. , Dottorini T. , Porciello R. , Giustini S. , Calvieri S. , Dallapiccola B.
      Hum. Mutat.23:629-629(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS NF1 ASN-157; ARG-629; SER-777; LYS-780; ARG-784; PRO-847; GLU-848; ARG-968; ASN-1444; LEU-1953 DEL AND ARG-2001;VARIANT GLU-176
    67. 68.
      "Automated comparative sequence analysis identifies mutations in 89% of NF1 patients and confirms a mutation cluster in exons 11-17 distinct from the GAP related domain."
      Mattocks C. , Baralle D. , Tarpey P. , ffrench-Constant C. , Bobrow M. , Whittaker J.
      J. Med. Genet.41:E48-E48(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS NF1 ARG-31; PRO-145; ARG-324; VAL-337; CYS-489; PRO-532; ARG-574; ARG-629; PHE-665; PHE-844; PRO-844; MET-991 DEL; VAL-1073; ARG-1196; GLY-1276; GLN-1276; GLU-1430; GLU-1459 DEL AND GLY-1489;VARIANTS GLU-176 AND CYS-873
    68. 69.
      "Neurofibromatous neuropathy in neurofibromatosis 1 (NF1)."
      Ferner R.E. , Hughes R.A.C. , Hall S.M. , Upadhyaya M. , Johnson M.R.
      J. Med. Genet.41:837-841(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT NF1 PRO-1243
    69. 70.
      "Neurofibromatosis-Noonan syndrome: molecular evidence of the concurrence of both disorders in a patient."
      Bertola D.R. , Pereira A.C. , Passetti F. , de Oliveira P.S.L. , Messiaen L. , Gelb B.D. , Kim C.A. , Krieger J.E.
      Am. J. Med. Genet. A136:242-245(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT NF1 ARG-844
    70. 71.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS NFNS ARG-194; GLU-1444; THR-1451; LEU-1453 AND GLU-1459 DEL
    71. 72.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS [LARGE SCALE ANALYSIS] ILE-1187; LEU-1951 AND ARG-2745
    72. 73.
      "Noonan syndrome and neurofibromatosis type I in a family with a novel mutation in NF1."
      Nystrom A.M. , Ekvall S. , Allanson J. , Edeby C. , Elinder M. , Holmstrom G. , Bondeson M.L. , Anneren G.
      Clin. Genet.76:524-534(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT NFNS PHE-1411
    73. 74.
      "Clinico-pathological and biomolecular findings in Italian patients with multiple cutaneous neurofibromas."
      Ponti G. , Losi L. , Martorana D. , Priola M. , Boni E. , Pollio A. , Neri T.M. , Seidenari S.
      Hered. Cancer Clin. Pract.9:6-6(2011) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT NF1 THR-160
    74. 75.
      "Exploring the somatic NF1 mutational spectrum associated with NF1 cutaneous neurofibromas."
      Thomas L. , Spurlock G. , Eudall C. , Thomas N.S. , Mort M. , Hamby S.E. , Chuzhanova N. , Brems H. , Legius E. , Cooper D.N. , Upadhyaya M.
      Eur. J. Hum. Genet.20:411-419(2012) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS GLU-176; THR-330; ASP-393; LEU-393; PRO-519; THR-776 AND PHE-1484
    75. 76.
      "Thirty-nine novel neurofibromatosis 1 (NF1) gene mutations identified in Slovak patients."
      Nemethova M. , Bolcekova A. , Ilencikova D. , Durovcikova D. , Hlinkova K. , Hlavata A. , Kovacs L. , Kadasi L. , Zatkova A.
      Ann. Hum. Genet.77:364-379(2013) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS NF1 TRP-93; ARG-1048; ARG-1189; ARG-1661 (ISOFORM 1) AND THR-1918 (ISOFORM 1)
    76. 77.
      "The mutational spectrum of the NF1 gene in neurofibromatosis type I patients from UAE."
      Ben-Salem S. , Al-Shamsi A.M. , Ali B.R. , Al-Gazali L.
      Childs Nerv. Syst.30:1183-1189(2014) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT NF1 PRO-2125
    Product Feedback Wall
    Hot Genes
    Atf2 ASPRO ACE ALCAM C19orf80 Trap1a Gdf5
    Top Searches
    Ubiquitin-protein ligase metalloproteinase Ubiquitin ELISA Tumor necrosis Alpha Asprosin TRAP1A
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2016 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter